Radiation Oncology · Acibadem Kayseri Hospital Prof. Bünyamin Kaplan, MD
✓ Medically verified profileProf. Bünyamin Kaplan, MD
Prof. Bünyamin Kaplan, MD is a radiation oncologist in the Radiation Oncology unit at Acibadem Kayseri Hospital in Kayseri, Turkey. His areas of expertise include radiotherapy for brain tumors and breast cancer, brachytherapy, and 3-D computerized treatment planning. He trained at Erciyes University Faculty of Medicine and consults in Turkish and English, with video consultation available.
Accepting international patientsAbout Prof. Bünyamin Kaplan, MD
Prof. Bünyamin Kaplan, MD is a radiation oncologist practicing in the Radiation Oncology unit at Acibadem Kayseri Hospital in Kayseri, Turkey. With more than 36 years in medicine, his work centers on radiotherapy for cancer, including the treatment of brain tumors and breast cancer, brachytherapy, and 3-D computerized treatment planning.
Dr. Kaplan graduated from Erciyes University Faculty of Medicine in 1990 and completed his specialty training in Radiation Oncology at the same faculty in 1996. During this period he completed a Medical Oncology rotation (1993) and a Brachytherapy/3-D Computerized Planning rotation (1995) at İstanbul University Oncology Institute. His academic career has been based at Erciyes University Faculty of Medicine, where he began as a research assistant in 1992 and held successive appointments up to the rank of professor, a title he has held since 2010. From 2000 to 2001 he was a Visiting Scientist at MD Anderson Cancer Center, Houston, Texas, USA. He worked part-time at Acıbadem Kayseri Hospital from 2009 to 2017 and at Medipol Mega Hospital, İstanbul from 2017 to 2019, before returning to Erciyes University Faculty of Medicine in 2019. He is a member of the Turkish Oncology Association, the Radyasyon Onkolojisi Association, the Turkish Cancer Research and Control Institution, and the Experimental and Clinical Research Association.
Clinical focus
Dr. Kaplan’s clinical practice covers radiation oncology across a range of cancer diagnoses. His stated areas of expertise include radiotherapy for brain tumors and breast cancer, as well as brachytherapy, in which a radiation source is placed close to or inside the area being treated. He also works with 3-D computerized treatment planning, a method used to shape the radiation dose to the target while taking surrounding tissues into account. Radiotherapy decisions depend on the individual diagnosis, stage and prior treatment, and are generally made together with other members of an oncology team.
His published research reflects a broad interest in radiation oncology. Co-authored papers have examined concurrent chemoradiotherapy in locally advanced non-small cell lung cancer, prognostic factors in elderly lung cancer patients, the effect of radiotherapy dose rates on early intestinal toxicity, nutritional status and psychiatric disorders in patients treated for head and neck cancer, and survival in patients with gastric cancer receiving adjuvant chemoradiotherapy.
How Dr. Kaplan works with international patients
Dr. Kaplan consults in Turkish and English, and interpreters can be arranged for other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination, and a discussion of the radiotherapy options relevant to the diagnosis. Video consultation is available for international patients who wish to discuss their case before traveling.
What Dr. Kaplan treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Conditions treated
Procedures performed
- Cancer oncology
- Radiotherapy
- Brachytherapy
- 3-D computerized treatment planning
- Brain tumors treatment
- Breast cancer treatment
Education, career and memberships
Education & training
Education
- 1996Erciyes University Faculty of Medicine Radyasyon Onkolojisi
- 1995İstanbul University Oncology Institute / Brachytherapy/3-D Computerized Planning Rotation
- 1993İstanbul University Oncology Institute / Medical Oncology Rotation
- 1990Erciyes University Faculty of Medicine
Career
Professional Experience
- 2019Erciyes University Faculty of Medicine / Prof.Dr.
- 2017–2019Medipol Mega Hospital, İstanbul / Prof.Dr.
- 2010–2017Acıbadem Kayseri Hospital (part-time) / Prof.Dr.
- 2010–2017Erciyes University Faculty of Medicine / Prof.Dr.
- 2009–2010Acıbadem Kayseri Hospital (part-time) / Doç.Dr.
- 2009Acıbadem Healthcare Services
- 2004–2009Erciyes University Faculty of Medicine / Doç.Dr.
- 2000–2009Erciyes University Faculty of Medicine / Yar.Doç. Dr.
- 2000–2001MD Anderson Cancer Center, Houston, Texas, USA / Visiting Scientist
- 1996–1999Erciyes University Faculty of Medicine / Uz.Öğ.Gör.
- 1992–1996Erciyes University Faculty of Medicine / Dr.Ar.Gör.
Memberships
Professional Memberships
- Turkish Oncology Association
- Radyasyon Onkolojisi Association
- Turkish Cancer Research and Control Institution
- Experimental and Clinical Research Association
Selected publications
Selected Publications
- Is human kallikrein-11 in non-small cell lung cancer treated chemoradiotherapy associated with survival? Cancer Res Treat. 2016;48(1):98-105. doi: 10.4143/crt.2014.364 D. Unal, C. Eroglu, A. Tasdemir, H. Karaman, N. Kurtul, B. Kaplan.
- Effect of radiotherapy dose rates on early intestinal toxicity. Turk J Oncol 2016;31(1):5-9. doi: 10.5505/tjo.2016.1399 . D. Ünal, S. Aydoğan, A. Taşdemir, T.D. Ünal, H. Çelik, H. Karaman, C. Eroğlu, B. Kaplan.
- Effect of radiotherapy on psychiatric disorder in patients with head and neck cancer Indian J Cancer. 2016;53(1):162-165. doi: 10.4103/0019-509X.180816 D. Unal, O. Orhan, S.D. Ozsoy, A. Besirli, C. Eroglu, B. Kaplan.
- Effect on long-term survival of psychiatric disorder, inflammation, malnutrition, and radiotherapy-related toxicity in patients with locally advanced head and neck cancer JBUON 2015;20(3):886-893. D. Unal, C. Eroglu C, S.D. Ozsoy, A. Besirli, O. Orhan, B. Kaplan
- Effect of prognostic factors on survival in elderly patients with non-small cell lung cancer. Turkish Journal of Geriatrics. 2014;17(2):113-118. D. Unal, A. Oguz, S.S. Goksu, A. Tasdemir, N. Kurtul, C. Eroglu, O. Orhan, B. Kaplan
- Prognostic value of SPARC expression in cases with unresectable NSCLC treated with concurrent chemoradiotherapy Asian Pac J Cancer Prev. 2014;15(20):8911-8916. doi: 10.7314/APJCP.2014.15.20.8911 N. Kurtul, C. Eroglu, D. Unal, E.A. Tasdemir, O. Orhan, G. Zararsız, M. Baran, O. Kontas, B. Kaplan.
- ABO Blood Groups are Not Associated with Treatment Response and Prognosis in Patients with Locally Advanced Non- Small Cell Lung Cancer. Asian Pac J Cancer Prev. 2013;14(6):3945-8. doi: 10.7314/APJCP.2013.14.6.3945 D. Unal, C. Eroglu, N. Kurtul, A. Oguz, A. Tasdemir, B. Kaplan.
- Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer Ann Thorac Med. 2013;8(2):109-115. doi: 10.4103/1817-1737.109824 C. Eroglu, O. Orhan, D. Unal, G.G. Dogu, H. Karaca, M. Dikilitas, A. Ozturk, M. Ozkan, B. Kaplan.
- The effect of being overweight on survival in patients with gastric cancer undergoing adjuvant chemoradiotherapy Eur J Cancer Care (Engl). 2013;22(1):133-140. doi: 10.1111/ecc.12010 C. Eroglu, O. Orhan, H. Karaca, D. Unal, M. Dikilitas, M. Ozkan, B. Kaplan.
- Prealbumin is a more sensitive marker than albumin to assess the nutritional status in patients undergoing radiotherapy for head and neck cancer. Wspolczesna Onkol (Contemporary Oncology) 2013;17(3):276-280. doi: 10.5114/wo.2013.35281 D. Unal, O. Orhan, C. Eroglu, B. Kaplan.
